特集 : 国別レポートが13,000件から検索可能になりました!

特集 : 海外市場の委託調査がセミカスタムベースでお手軽にできます

株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

OTC医薬品・医療機器・診断薬:世界市場

OTC Drugs, Medical Devices and Diagnostics: Global Markets

発行 BCC Research 商品コード 941891
出版日 ページ情報 英文 317 Pages
即納可能
価格
本日の銀行送金レート: 1USD=107.13円で換算しております。
OTC医薬品・医療機器・診断薬:世界市場 OTC Drugs, Medical Devices and Diagnostics: Global Markets
出版日: 2020年06月05日 ページ情報: 英文 317 Pages
概要

世界のOTC医薬品・医療機器・診断薬の市場規模は、2019~2024年に6.9%のCAGRで成長し、2019年の2590億米ドルから、2024年には3610億米ドルにまで拡大する、と予測されています。

当レポートでは、世界のOTC (over the counter) 医薬品・医療機器・診断薬の市場について分析し、製品の概略や市場の基本構造 (対象となる主な疾患・障害など)、現在の市場範囲とアンメットニーズ、市場規模・成長率の動向見通し、主な市場促進・抑制要因、現在の研究開発・資本取引の動向と展望、規制環境、今後の市場成長の可能性・方向性、主要企業のプロファイル、といった情報を取りまとめてお届けいたします。

第1章 イントロダクション

第2章 サマリー・ハイライト

第3章 対象となる疾患と障害

  • OTCの対象となる一般的な疾患・障害:概要
    • 循環器疾患
    • 生活習慣病
    • 呼吸器疾患
    • 筋骨格障害
    • 精神/気分障害
    • 胃腸障害
    • 泌尿器疾患
    • 慢性創傷
    • 慢性疼痛
    • パニック障害/不安障害
    • 耳鼻咽喉科 (ENT) 疾患
    • 歯科疾患
    • 摂食障害
  • 喫煙と関連疾患
  • 慢性疾患:OTC市場の範囲の拡張
  • 老化・性別と病気の発症
    • 世界の人口統計
    • 米国の人口統計
    • 米国:性別、年齢、平均余命
    • 欧州の人口統計
    • 日本の人口統計
  • 現在の課題と今後の方向性

第4章 OTC医薬品と栄養補助食品

  • OTC治療薬の概要
  • OTC医薬品の進化
  • 薬物の臨床的必要性
  • 薬物ベースの疾患管理
    • ジェネリック医薬品と疾病管理
    • ジェネリック医薬品とブランド医薬品
    • ジェネリックに対する継続的な抵抗感
  • OTC医薬品とその種類
    • OTC鎮痛剤/解熱剤
    • OTC抗ヒスタミン薬・鎮咳剤・風邪薬
    • OTC胃腸薬
    • OTC皮膚薬
    • OTC口腔ケア製品
    • OTCアイケア製品
    • OTC禁煙製品
  • 主な上市済みOTC医薬品
  • OTC栄養補助食品 (サプリメント) とその種類
    • 摂食障害
    • ビタミン・ミネラル欠乏症の治療
    • ビタミン/ミネラルサプリメント(VMS)
  • OTCの流通チャネル
    • 多国籍OTC医薬品メーカー
    • ドラッグストア、その他のチェーンストアブランド
    • 日用消費財 (FMCG)
  • OTC医薬品購入の実践
  • OTC医薬品市場への規制の影響
  • OTC医薬品・栄養補助食品の市場状況
    • 先進国市場
    • 発展途上国市場
    • 低開発国市場
  • 治療と費用負担
  • アンメットニーズ
  • 現在の課題と今後の展開

第5章 OTC医療機器・診断薬

  • 医療機器、診断、疾病管理
  • OTC医療装置・診断薬:臨床現場/市場での必要性
  • OTC医療機器・診断薬の種類
    • 自己治療用デバイスとウェアラブル機器
    • 診断装置・キット
  • 主な製品
    • 診断・監視デバイス
    • 治療装置とテクノロジー
  • 遠隔患者モニタリングと在宅治療
  • デジタル治療による疾病管理の利点
  • アンメットニーズ
  • 現在の課題
  • 今後の展望

第6章 治療遵守 (アドヒランス) 用のOTCデバイス

  • 治療不順守
  • OTC医薬品アドヒアランス装置の市場ニーズ
  • ハードウェア中心型OTC医薬品アドヒアランス装置
    • スマート薬瓶
    • 自動錠剤ディスペンサー
    • 電子トレイ
    • スマートキャップ
    • その他のアドヒランス装置とソリューション
  • 主な製品
    • スマートピルディスペンサー、ピルボックス、オーガナイザー、スマートピルキャップ、ボトルシステム
    • その他のOTC付着装置
  • 現在の課題
  • 今後の展開

第7章 市場規模と成長分析

  • 市場規模・成長率の分析
    • 市場規模・成長率の分析:地域別
    • 市場規模・成長率の分析:製品区分別
    • 市場規模・成長率の分析:疾患の種類別
  • 市場促進・抑制要因
  • OTC市場への規制の影響
  • 欧州のOTC市場に対するBrexitの影響
  • OTC市場のSWOT分析

第8章 OTCの薬剤、医療機器および診断の市場の競合情勢

  • 競合情勢環境:OTC薬、医療機器、診断技術別疾患の治療と管理

第9章 OTCの薬剤、医療機器および診断の市場の作戦

  • OTC医薬品・医療機器市場における企業再編
  • OTC医薬品・医療機器・診断薬市場における企業合併・買収 (M&A)
  • 昨今のM&A
  • 今後の戦略的展望

第10章 規制構造:医薬品、医療機器、診断

  • 規制の背景
  • 医療機器の規制制度:地域別
    • 米国
    • 欧州
    • 日本
  • 医薬品の規制制度:地域別
  • OTC医薬品・栄養補助食品の規則と規制

第11章 価格と償還:医薬品、医療機器、診断

  • 価格・医療費償還の背景事情
  • 医療機器の価格・医療費償還:地域別
  • 医薬品の価格・医療費償還:地域別

第12章 結論:OTC医薬品・医療機器・診断薬市場の将来展望

  • 市場に影響を与える主な動向
    • 技術開発
    • 人口動態・経済動向
    • 医療産業の構造変化
    • ライフスタイル医学
    • 患者中心のプログラム
    • セルフケアの有病率
    • 公衆衛生システムへの負担
    • 市場のリーダーシップの維持
  • 長期的展望

第13章 企業プロファイル

  • 3M
  • ABBOTT LABORATORIES
  • ABBVIE INC.
  • ACADIA PHARMACEUTICAL
  • ACORDA THERAPEUTICS
  • ACTAVIS PLC
  • ACTUALMEDS
  • ADHERIUM
  • AETHLON MEDICAL INC.
  • AGENUS
  • AKRON
  • ALACER CORP.
  • ALCON INC.
  • ALERE INC.
  • ALFRESA PHARMA CORP.
  • ALIPHCOM INC.
  • ALIVECOR
  • ALKALON A/S
  • ALKERMES
  • ALLERGAN
  • ALLIANCE HEALTHCARE
  • AMGEN INC.
  • AMIKO
  • AMNEAL PHARMACEUTICALS
  • ANAVEX LIFE SCIENCES
  • ANI PHARMACEUTICALS
  • ANIMAS (JOHNSON & JOHNSONの子会社)
  • APOTEX
  • ARCHOS
  • ARENA PHARMACEUTICALS
  • ARRAY BIOPHARMA
  • 旭化成
  • ASLAN PHARMACEUTICALS
  • ASPEN PHARMACARE
  • ASSERTIO THERAPEUTICS, INC.
  • アステラス製薬
  • ASTRAZANECA PLC
  • ATHERSYS
  • AUDENTES THERAPEUTICS
  • AXIOBIONICS
  • AXSOME THERAPEUTICS
  • BAUSCH & LOMB
  • BAUSCH HEALTH
  • BAXTER INTERNATIONAL INC.
  • BAYER AG
  • BEIGENE
  • BESPAK EUROPE
  • BIOMERIEUX
  • BIOSENSICS
  • BIOSERENITY
  • BIOTRICITY
  • BIOTRONIK
  • BIOVOTION
  • BIOXCEL THERAPEUTICS
  • BODYTEL
  • BOEHRINGER INGELHEIM
  • BOSTON SCIENTIFIC
  • BRAINMARC
  • BRISTOL-MYERS SQUIBB
  • BTS BIOENGINEERING
  • CARDIOMEMS INC. (ST. JUDEの子会社)
  • CARMA LABORATORIES, INC.
  • CELGENE
  • CHATTEM INC.
  • CHUGAI PHARMACEUTICALS CO. LTD.
  • CILAG AG
  • CIPLA
  • CLEVELAND MEDICAL DEVICES
  • COLGATE-PALMOLIVE CO.
  • CONNECTEDHEALTH PTE. LTD.
  • CONSORT MEDICAL
  • CORBUS PHARMACEUTICALS
  • CSPC PHARMACEUTICAL GROUP
  • 第一三共
  • DERMA SCIENCES
  • DEXCOM INC.
  • DR. REDDY'S LABORATORIES LTD.
  • EARLYSENSE
  • エーザイ
  • ELI LILLY AND CO.
  • EMPATICA
  • ENDO INTERNATIONAL
  • ENDOCEUTICS INC.
  • ENDOTRONIX
  • ENTRA HEALTH SYSTEMS
  • ERYTECH PHARMA
  • ESTEVE
  • EVERIST HEALTH
  • EYESCIENCE LABS
  • FERTIN PHARMA A/S
  • GABA SCHWEIZ
  • GALDERMA S.A.
  • GEMINI PHARMACEUTICALS INC.
  • GENOMMA LAB INTERNATIONAL
  • GENOMMA LAB USA
  • GILEAD SCIENCES
  • GLAXOSMITHKLINE PLC
  • GLOOKO INC.
  • GLUCOVISTA INC.
  • HEALTH CARE ORIGINALS
  • HIKMA PHARMACEUTICALS
  • 久光製薬
  • HOCOMA
  • IHEALTH LAB INC.
  • IMMUNOMEDICS
  • IMPACT SPORTS TECHNOLOGIES
  • IMPAK HEALTH
  • INFOBIONIC INC.
  • INSULET CORP.
  • INTELESENS
  • INTRA-CELLULAR THERAPIES
  • IOVANCE BIOTHERAPEUTICS
  • IPSEN S.A.
  • JAN MEDICAL INC.
  • JIANGSU HENGRUI MEDICINE
  • JOHNSON & JOHNSON
  • 興和
  • 協和発酵キリン
  • LAKE CONSUMER PRODUCTS INC.
  • LES LABORATOIRES SERVIER
  • LIVANOVA PLC
  • LUNDBECK
  • LUPIN
  • MALLINCKRODT PLC
  • MANX HEALTHCARE LTD.
  • MCM KLOSTERFRAU VERTRIEBS GMBH (KLOSTERFRAU HEALTHCARE GROUP)
  • MEDA AB
  • MEDMINDER
  • MEDTRONIC
  • MEDTRONIC MINIMED INC. (MEDTRONICの子会社)
  • MELALEUCA INC.
  • MENARINI
  • MERCK
  • MERZ PHARMA
  • MIO GLOBAL
  • 田辺三菱製薬
  • 持田製薬
  • MYCARDIO LLC
  • MYLAN INC.
  • NEMAURA MEDICAL INC.
  • NEOFECT CO. LTD.
  • NEUROCRINE BIOSCIENCES
  • NEUROMETRIX INC.
  • NEUROVIGIL INC.
  • NEUTROGENA CORP.
  • NORTHEAST PHARMACEUTICAL GROUP CO. LTD.
  • NOVARTIS
  • NOVASOM INC.
  • NOVO NORDISK
  • NOW FOODS
  • NUCANA
  • OMADA HEALTH INC.
  • OMNICELL INC.
  • オムロン
  • 小野薬品工業
  • ORION PHARMA LTD.
  • ORPYX MEDICAL TECHNOLOGIES
  • 大塚製薬
  • PACIRA PHARMACEUTICALS INC.
  • PERRIGO PLC
  • PFIZER
  • PGT HEALTHCARE (PROCTER & GAMBLEの一部門)
  • PHARMAVITE LLC
  • PHILOSYS
  • PIERRE FABRE PHARMACEUTICALS INC.
  • PIRAMAL HEALTHCARE LTD.
  • POLAR ELECTRO OY
  • PRESTIGE BRANDS HOLDINGS INC.
  • PREVENTICE INC.
  • PRIZM MEDICAL INC.
  • PROPELLER HEALTH
  • PROTEOSTASIS THERAPEUTICS
  • PROTEUS DIGITAL HEALTH INC.
  • QARDIO
  • RECKITT BENCKISER (NORTH AMERICA) INC.
  • RECKITT BENCKISER PLC.
  • RECORDATI PHARMA GMBH
  • REHAB-ROBOTICS (VINCENT MEDICAL HOLDINGSのメンバー)
  • REVOLYMER (U.K.) LTD
  • REXAHN PHARMACEUTICALS
  • ROCHE
  • SAGE PRODUCTS LLC
  • SAGE THERAPEUTICS
  • SANOFI
  • SAREPTA THERAPEUTICS
  • 佐藤製薬
  • SENSE4CARE
  • SENSEONICS HOLDINGS
  • SENTICARE INC.
  • SHAKLEE CORP.
  • SHANGHAI PHARMACEUTICALS HOLDING
  • 塩野義製薬
  • SILVERGENS
  • SPROUTLING INC. (MATTELが買収済み)
  • ST. JUDE MEDICAL (ABBOTT LABORATORIESの子会社)
  • STADA ARZNEIMITTEL AG
  • 大日本住友製薬
  • SUN PHARMACEUTICAL INDUSTRIES
  • SWISSE WELLNESS PTY LTD.
  • 大正製薬ホールディングス
  • 大正製薬
  • 武田薬品工業
  • TCR2 THERAPEUTICS
  • TEVA PHARMACEUTICAL INDUSTRIES
  • TISSO NATURPRODUKTE GMBH
  • TOWERVIEW HEALTH INC.
  • TRANSLATE BIO
  • TYME TECHNOLOGIES
  • UCB
  • UNILIFE CORP.
  • VAICA
  • VERTEX PHARMACEUTICAL
  • VITAL CONNECT
  • WELLSPRING PHARMACEUTICAL CORP.
  • WEST PHARMACEUTICAL SERVICES INC.
  • WINMEDICAL SRL
  • YBRAIN
  • YPSOMED HOLDING AG
  • ZEAVISION LLC
  • ZOGENIX INC.
  • ZYDUS CADILA

第14章 付録A:略語一覧

第15章 付録B:専門機関の一覧

図表

List of Tables

  • Summary Table : Global Market for OTC Drugs, Medical Devices and Diagnostics, by Country/Region, Through 2024
  • Table 1 : Global Incidence Share of Hypertension, by Patient Group Type, 2019
  • Table 2 : Global Prevalence of Angina Pectoris and Stroke (Survivors), Through 2030
  • Table 3 : Global Prevalence of Congestive Heart Failure and Stroke, Through 2030
  • Table 4 : Structural Heart Disease Management Through Medication
  • Table 5 : BMI Calculation
  • Table 6 : BMI Categories Based on Increasing Health Risks
  • Table 7 : Trends in Obesity Composition of the World's Population, Through 2025
  • Table 8 : Obesity and Severe Obesity vs. General Population in U.S., Through 2025
  • Table 9 : Global Share of Diabetes, by Type
  • Table 10 : Global Prevalence of Diabetes, by Type, Through 2040
  • Table 11 : Global Symptomatic Prevalence of Key Musculoskeletal Disorders, Through 2025
  • Table 12 : Global Deaths, by Various Musculoskeletal Disorders, Through 2030
  • Table 13 : Global Deaths from Digestive Diseases, by Region, Through 2025
  • Table 14 : Global Deaths Share, by Various Chronic Disease Types, 2018
  • Table 15 : Global DALYs Share, by Various Chronic Disease Types, 2018
  • Table 16 : Estimated World Population and Annual Growth, by Age Group, Through 2030
  • Table 17 : World Population, by Country/Region, Through 2030
  • Table 18 : U.S. Population Estimates and Projections, by Age Group, Through 2030
  • Table 19 : Estimates of Anticipated U.S. Life Expectancy at Birth, by Gender, Through 2020
  • Table 20 : European Population Estimates and Projections, by Age Group, Through 2030
  • Table 21 : Japanese Population Estimates and Projections, by Age Group, Through 2030
  • Table 22 : Key Marketed OTC Drugs
  • Table 23 : Cardiac Monitoring Devices and Technologies, by Company
  • Table 24 : Key Continuous Glucose Monitoring Devices and Technologies, by Company
  • Table 25 : Sleep-Monitoring Devices and Technologies, by Company
  • Table 26 : Key Vital Sign and Activity Monitoring Devices and Technologies, by Company
  • Table 27 : Pain Management Devices and Technologies, by Company
  • Table 28 : Drug Delivery Devices and Technologies, by Company
  • Table 29 : Insulin Delivery Devices and Technologies, by Company
  • Table 30 : Global Medication Adherence Percentages, by Chronic Diseases
  • Table 31 : Smart Pill Dispensers, Pillboxes and Organizers, by Company
  • Table 32 : Medication Tracking Devices and Apps, by Company
  • Table 33 : Pill Organizer and Reminder Systems, by Company
  • Table 34 : Smart Pill Cap and Bottle Systems, by Company
  • Table 35 : Other Medication Adherence Solutions, by Company
  • Table 36 : Global Market for OTC Drugs, Medical Devices and Diagnostics, by Country/Region, Through 2024
  • Table 37 : Global Market for OTC Drugs, Medical Devices and Diagnostics, by Product Segment, Through 2024
  • Table 38 : Global Market for OTC Treatment Adherence Devices, Through 2024
  • Table 39 : Global Market for OTC Drugs, Medical Devices and Diagnostics, by Disease Type, Through 2024
  • Table 40 : SWOT Analysis of the OTC Drugs, Medical Devices and Diagnostics Market
  • Table 41 : Global Market for OTC Drugs, Medical Devices and Diagnostics, by Company, 2019
  • Table 42 : Key Strategic Deals in the OTC Medical Devices and Diagnostics Market, by Company, 2012-2019
  • Table 43 : Key Strategic Deals in OTC Drugs and Nutritional Product/Supplement Market, by Company, 2016-2019
  • Table 44 : Key Strategic Deals for Business Units, Minority Stakes and Future Options to Acquire in the OTC Market, by Company, 2016-2019
  • Table 45 : Differences in Regulatory Approval in the U.S. and Europe
  • Table 46 : Trends in Per Capita Real Gross Domestic Product Growth, by Region, 2015-2018
  • Table 47 : List of Acronyms used in OTC Drugs, Medical Devices and Diagnostics

List of Figures

  • Summary Figure : Global Market for OTC Drugs, Medical Devices and Diagnostics, by Country/Region, 2018-2024
  • Figure 1 : Global Incidence Share of Hypertension, by Patient Group Type, 2019
  • Figure 2 : Global Prevalence of Angina Pectoris and Stroke (Survivors), 2004-2030
  • Figure 3 : Global Prevalence of Congestive Heart Failure and Stroke, 2004-2030
  • Figure 4 : Trends in Obesity Composition of the World's Population, 2012-2025
  • Figure 5 : Obesity and Severe Obesity vs. General Population in U.S., 2018 and 2025
  • Figure 6 : Global Share of Diabetes, by Type
  • Figure 7 : Global Prevalence of Diabetes, by Type, 2018 and 2040
  • Figure 8 : Global Symptomatic Prevalence of Key Musculoskeletal Disorders, 2012-2025
  • Figure 9 : Global Deaths Share, by Various Musculoskeletal Disorders, 2015
  • Figure 10 : Global Deaths from Digestive Diseases, by Region, 2015-2025
  • Figure 11 : Global Deaths Share, by Various Chronic Disease Types, 2018
  • Figure 12 : Global DALYs Share, by Various Chronic Disease Types, 2018
  • Figure 13 : Estimated World Population and Annual Growth, by Age Group, 2000-2030
  • Figure 14 : World Population, by Country/Region, 2000-2030
  • Figure 15 : U.S. Population Estimates and Projections, by Age Group, 2000-2030
  • Figure 16 : Estimates of Anticipated U.S. Life Expectancy at Birth, by Gender, 2005-2020
  • Figure 17 : European Population Estimates and Projections, by Age Group, 2000-2030
  • Figure 18 : Japanese Population Estimates and Projections, by Age Group, 2000-2030
  • Figure 19 : Global Market for OTC Drugs, Medical Devices and Diagnostics, by Country/Region, 2018-2024
  • Figure 20 : Global Market for OTC Drugs, Medical Devices and Diagnostics, by Product Segment, 2018-2024
  • Figure 21 : Global Market Share for OTC Drugs, Medical Devices and Diagnostics, by Product Segment, 2019
  • Figure 22 : Global Market Share for OTC Drugs and Nutritional Supplements, by Therapeutic Classification, 2019
  • Figure 23 : Global Market Share for Device Technologies, by Device Type, 2019
  • Figure 24 : Global Market for OTC Treatment Adherence Devices, 2018-2024
  • Figure 25 : Global Market for OTC Drugs, Medical Devices and Diagnostics, by Disease Type, 2018-2024
  • Figure 26 : Trends in Per Capita Real Gross Domestic Product Growth, by Region, 2015-2018
目次
Product Code: HLC251A

Highlights:

The global market for OTC drugs, medical devices and diagnostics should grow from $259 billion in 2019 to $361 billion by 2024 at compound annual growth rate (CAGR) of 6.9% for the period of 2019-2024.

U.S. market for OTC drugs, medical devices and diagnostics should grow from $91 billion in 2019 to $128 billion by 2024 at a CAGR of 7.1% for the period of 2019-2024.

Asia-Pacific market for OTC drugs, medical devices and diagnostics should grow from $57 billion in 2019 to $83 billion by 2024 at a CAGR of 7.8% for the period of 2019-2024.

Report Scope:

This report is an analytical business tool with the primary purpose of providing a thorough evaluation of the global market for OTC drugs, medical devices and diagnostic kits used for self-care and the management of various common diseases.

The report considers only "Western" or modern drugs and excludes any other type of drugs such as alternative therapies. This report covers medical devices and diagnostic kits exempted by the U.S. FDA for OTC use.

This study aims to provide an understanding of the dynamics and forecasts of the OTC drugs, medical devices and diagnostic kits market worldwide and provides key market propositions over a five-year forecast period.

The report covers developed and emerging markets in order to help readers understand -

  • Detailed description, including demographics and cost burden, of various diseases including cardiovascular diseases, orthopedic diseases, respiratory disorders, diabetes, obesity, gastrointestinal disorders, sleep disorders, skin disorders, and ENT disorders.
  • Detailed description and analysis of current OTC drugs, medical devices and diagnostic kits.
  • Market characterization, unmet need, and market size and segmentation (by region, by segment, by diseases).
  • The current state of the market and the key markets for its future development.
  • Major regional trends.
  • Market drivers and restraints.
  • Detailed market projections through 2024.
  • Global competitive thrust in terms of competition and market shares.
  • Key marketed and pipeline (research and development) products along with information about their regulatory status.
  • Strategic landscape (mergers and acquisitions).
  • Regulatory structure: new regulations that will influence the development of the OTC drugs, devices and diagnostics market.
  • Pricing and reimbursement.
  • Observations and conclusions on the future of OTC drugs, medical devices and diagnostics.
  • Profiles of market participants and associations.

Report Includes:

  • 26 data tables and 22 additional tables
  • An overview of the global markets for over-the-counter (OTC) drugs, medical devices and diagnostics
  • Analyses of global market trends with data from 2018 and 2019, and projections of compound annual growth rates (CAGRs) through 2024
  • Coverage of various target diseases, including common health disorders and severe chronic diseases where OTC drugs and devices play a key role in the management of diseases
  • Assessment of the recent breakthroughs, current research activities, technological hurdles and latest trends related to the field of medical technologies
  • Complete understanding about the usage and adoption rate of OTC drugs, devices and diagnostic kits in various regions
  • Underlying details of key business opportunities to pivotal stakeholders to expand of business and capture the revenue in the specific verticals to analyze before investing or expanding the horizon within this market
  • Competitive landscape encompassing a large chunk of small, medium and large players on both pharmaceutical drugs and medical devices and diagnostics side
  • Profile description of leading market players, including 3M, Akron, Bayer AG, Celgene, and Eli Lilly and Co.

Table of Contents

Chapter 1 Introduction

  • Study Goals and Objectives
  • Reasons for Doing This Study
  • Scope of Report
  • Intended Audience
  • Methodology and Information Sources
  • Geographic Breakdown
  • Analyst's Credentials
  • BCC Custom Research
  • Related BCC Research Reports

Chapter 2 Summary and Highlights

Chapter 3 Target Diseases and Disorders

  • Overview of Common Diseases and Disorders for OTC
  • Cardiovascular Disease
  • Lifestyle Disorders
  • Respiratory Disorders
  • Musculoskeletal Disorders
  • Mental/Mood Disorders
  • Gastrointestinal Disorders
  • Urology Disorders
  • Chronic Wounds
  • Chronic Pain
  • Panic Disorder/Anxiety Disorder
  • ENT Disorders
  • Dental Disorders
  • Eating Disorders
  • Tobacco Smoking and Associated Diseases
  • Chronic Diseases: Expanding Horizon for OTC Market
  • Aging, Gender and Onset of Diseases
  • Global Demographics
  • U.S. Demographics
  • U.S.: Gender, Age and Life Expectancy
  • European Demographics
  • Japanese Demographics
  • Current Challenges and Future Directions

Chapter 4 OTC Drugs and Nutritional Supplements

  • OTC Therapeutics Overview
  • Evolution of OTC drugs
  • Clinical Need of Drugs
  • Drug-Based Disease Management
  • Generic Drugs and Disease Management
  • Generic Drugs vs. Branded Drugs
  • Continued Resistance to Generics
  • OTC Drugs and Types
  • OTC Analgesics/Antipyretics
  • OTC Antihistamine and Cough and Cold Drugs
  • OTC Gastrointestinal Products
  • OTC Dermatological Drugs
  • OTC Oral Medical Care Products
  • OTC Eye Care Products
  • OTC Smoking Cessation Products
  • Key Marketed OTC Drugs
  • OTC Dietary Supplements and Types
  • Eating Disorders
  • Treatments for Vitamin and Mineral Deficiency
  • Vitamin and Mineral Supplements (VMS)
  • Distribution Channel for OTC
  • Multinational OTC Drug Manufacturers
  • Drug Stores and Other Chain Store Brands
  • FMCGs
  • Practice of OTC Drug Purchase
  • Regulatory Influence on OTC Drug Market
  • Market Situation for OTC Drugs and Dietary Supplements
  • Well-Developed Markets
  • Developing Markets
  • Underdeveloped Markets
  • Therapeutics and Cost Burden
  • Unmet Need
  • Current Challenges and Future Developments

Chapter 5 OTC Medical Devices and Diagnostics

  • Medical Devices, Diagnostics and Disease Management
  • Clinical and Market Need of OTC Devices and Diagnostics
  • Types of OTC Devices and Diagnostics
  • Self-Care Devices and Wearables
  • Diagnostic Devices and Kits
  • Key Products
  • Diagnostic and Monitoring Devices
  • Therapeutic Devices and Technologies
  • Remote Patient Monitoring and Home Healthcare
  • Advantages of Disease Management via Digital Care
  • Unmet Need
  • Current Challenges
  • Future Outlook

Chapter 6 OTC Devices for Treatment Adherence

  • Treatment Nonadherence
  • Market Need for OTC Medication Adherence Devices
  • Hardware-Centric OTC Medication Adherence Devices
  • Smart Pill Bottle
  • Automated Pill Dispenser
  • Electronic Tray
  • Smart Caps
  • Other Adherence Devices and Solutions
  • Key Products
  • Smart Pill Dispensers, Pillboxes, Organizers, Smart Pill Cap and Bottle Systems
  • Other OTC Adherence Devices
  • Current Challenges
  • Future Developments

Chapter 7 Market Size and Growth Analysis

  • Market Size and Growth Analysis
  • Market Size and Growth Analysis, by Region
  • Market Size and Growth Analysis, by Product Segment
  • Market Size and Growth Analysis, by Disease Type
  • Market Growth Drivers and Restraints
  • Market Growth Drivers
  • Market Restraints
  • Regulatory Impact on the OTC Market
  • Brexit Effect on the OTC Market in Europe
  • SWOT Analysis of OTC Market

Chapter 8 Competitive Landscape in the OTC Drugs, Medical Devices and Diagnostics Market

  • Competitive Landscape: Disease Treatment and Management with OTC Drugs, Medical Devices and Diagnostic Technologies

Chapter 9 Strategies in the OTC Drugs, Medical Devices and Diagnostics Market

  • Consolidation in the OTC Drugs and Devices Market
  • Mergers and Acquisitions in the OTC Drugs, Medical Devices and Diagnostics Market
  • OTC Drugs and Nutritional Products (Vitamin and Mineral Supplements)
  • OTC Medical Devices and Diagnostics
  • Recent Mergers and Acquisitions
  • OTC Medical Devices and Diagnostics
  • OTC Drugs and Nutritional Products (Vitamin and Mineral Supplements)
  • Minority Stakes and Future Options to Acquire
  • Future Strategic Landscape

Chapter 10 Regulatory Structure: Pharmaceuticals, Medical Devices and Diagnostics

  • Regulatory Background
  • Regulatory Systems for Medical Devices, by Region
  • U.S.
  • European Union
  • Japan
  • Regulatory Systems for Pharmaceuticals, by Region
  • U.S.
  • Europe
  • Japan
  • Rules and Regulations for OTC Drugs and Dietary Supplements
  • Regulations for OTC drugs
  • Regulations for Dietary Supplements

Chapter 11 Pricing and Reimbursement: Pharmaceuticals, Medical Devices and Diagnostics

  • Pricing and Reimbursement Background
  • Pricing and Reimbursement for Medical Devices, by Region
  • U.S.
  • Europe
  • Japan
  • Other Asia-Pacific
  • Pricing and Reimbursement for Pharmaceuticals, by Region
  • U.S.
  • Europe
  • Japan

Chapter 12 Conclusions-Outlook for OTC Drugs, Medical Devices and Diagnostics

  • Major Developments Influencing the Market
  • Technological Developments
  • Demographic and Economic Trends
  • Changing Structure of the Healthcare Industry
  • Lifestyle Medicine
  • Patient-Centric Programs
  • Prevalence of Self-Care
  • Burden on Public Health System
  • Retain Market Leadership
  • Long-Term Outlook

Chapter 13 Company Profiles

  • 3M
  • ABBOTT LABORATORIES
  • ABBVIE INC.
  • ACADIA PHARMACEUTICAL
  • ACORDA THERAPEUTICS
  • ACTAVIS PLC
  • ACTUALMEDS
  • ADHERIUM
  • AETHLON MEDICAL INC.
  • AGENUS
  • AKRON
  • ALACER CORP.
  • ALCON INC.
  • ALERE INC.
  • ALFRESA PHARMA CORP.
  • ALIPHCOM INC.
  • ALIVECOR
  • ALKALON A/S
  • ALKERMES
  • ALLERGAN
  • ALLIANCE HEALTHCARE
  • AMGEN INC.
  • AMIKO
  • AMNEAL PHARMACEUTICALS
  • ANAVEX LIFE SCIENCES
  • ANI PHARMACEUTICALS
  • ANIMAS (A SUBSIDIARY OF JOHNSON & JOHNSON)
  • APOTEX
  • ARCHOS
  • ARENA PHARMACEUTICALS
  • ARRAY BIOPHARMA
  • ASAHI KASAI CORP.
  • ASLAN PHARMACEUTICALS
  • ASPEN PHARMACARE
  • ASSERTIO THERAPEUTICS, INC.
  • ASTELLAS PHARMA INC.
  • ASTRAZANECA PLC
  • ATHERSYS
  • AUDENTES THERAPEUTICS
  • AXIOBIONICS
  • AXSOME THERAPEUTICS
  • BAUSCH & LOMB
  • BAUSCH HEALTH
  • BAXTER INTERNATIONAL INC.
  • BAYER AG
  • BEIGENE
  • BESPAK EUROPE
  • BIOMERIEUX
  • BIOSENSICS
  • BIOSERENITY
  • BIOTRICITY
  • BIOTRONIK
  • BIOVOTION
  • BIOXCEL THERAPEUTICS
  • BODYTEL
  • BOEHRINGER INGELHEIM
  • BOSTON SCIENTIFIC
  • BRAINMARC
  • BRISTOL-MYERS SQUIBB
  • BTS BIOENGINEERING
  • CARDIOMEMS INC. (A SUBSIDIARY OF ST. JUDE)
  • CARMA LABORATORIES, INC.
  • CELGENE
  • CHATTEM INC.
  • CHUGAI PHARMACEUTICALS CO. LTD.
  • CILAG AG
  • CIPLA
  • CLEVELAND MEDICAL DEVICES
  • COLGATE-PALMOLIVE CO.
  • CONNECTEDHEALTH PTE. LTD.
  • CONSORT MEDICAL
  • CORBUS PHARMACEUTICALS
  • CSPC PHARMACEUTICAL GROUP
  • DAIICHI SANKYO
  • DERMA SCIENCES
  • DEXCOM INC.
  • DR. REDDY'S LABORATORIES LTD.
  • EARLYSENSE
  • EISAI
  • ELI LILLY AND CO.
  • EMPATICA
  • ENDO INTERNATIONAL
  • ENDOCEUTICS INC.
  • ENDOTRONIX
  • ENTRA HEALTH SYSTEMS
  • ERYTECH PHARMA
  • ESTEVE
  • EVERIST HEALTH
  • EYESCIENCE LABS
  • FERTIN PHARMA A/S
  • GABA SCHWEIZ
  • GALDERMA S.A.
  • GEMINI PHARMACEUTICALS INC.
  • GENOMMA LAB INTERNATIONAL
  • GENOMMA LAB USA
  • GILEAD SCIENCES
  • GLAXOSMITHKLINE PLC
  • GLOOKO INC.
  • GLUCOVISTA INC.
  • HEALTH CARE ORIGINALS
  • HIKMA PHARMACEUTICALS
  • HISAMITSU PHARMACEUTICAL CO. INC.
  • HOCOMA
  • IHEALTH LAB INC.
  • IMMUNOMEDICS
  • IMPACT SPORTS TECHNOLOGIES
  • IMPAK HEALTH
  • INFOBIONIC INC.
  • INSULET CORP.
  • INTELESENS
  • INTRA-CELLULAR THERAPIES
  • IOVANCE BIOTHERAPEUTICS
  • IPSEN S.A.
  • JAN MEDICAL INC.
  • JIANGSU HENGRUI MEDICINE
  • JOHNSON & JOHNSON
  • KOWA CO. LTD.
  • KYOWA HAKKO KIRIN
  • LAKE CONSUMER PRODUCTS INC.
  • LES LABORATOIRES SERVIER
  • LIVANOVA PLC
  • LUNDBECK
  • LUPIN
  • MALLINCKRODT PLC
  • MANX HEALTHCARE LTD.
  • MCM KLOSTERFRAU VERTRIEBS GMBH (KLOSTERFRAU HEALTHCARE GROUP)
  • MEDA AB
  • MEDMINDER
  • MEDTRONIC
  • MEDTRONIC MINIMED INC. (A SUBSIDIARY OF MEDTRONIC)
  • MELALEUCA INC.
  • MENARINI
  • MERCK
  • MERZ PHARMA
  • MIO GLOBAL
  • MITSUBISHI TANABE PHARMA
  • MOCHIDA PHARMACEUTICAL CO. LTD.
  • MYCARDIO LLC
  • MYLAN INC.
  • NEMAURA MEDICAL INC.
  • NEOFECT CO. LTD.
  • NEUROCRINE BIOSCIENCES
  • NEUROMETRIX INC.
  • NEUROVIGIL INC.
  • NEUTROGENA CORP.
  • NORTHEAST PHARMACEUTICAL GROUP CO. LTD.
  • NOVARTIS
  • NOVASOM INC.
  • NOVO NORDISK
  • NOW FOODS
  • NUCANA
  • OMADA HEALTH INC.
  • OMNICELL INC.
  • OMRON CORP.
  • ONO PHARMACEUTICAL CO. LTD.
  • ORION PHARMA LTD.
  • ORPYX MEDICAL TECHNOLOGIES
  • OTSUKA PHARMACEUTICALS
  • PACIRA PHARMACEUTICALS INC.
  • PERRIGO PLC
  • PFIZER
  • PGT HEALTHCARE (DIVISION OF PROCTER & GAMBLE)
  • PHARMAVITE LLC
  • PHILOSYS
  • PIERRE FABRE PHARMACEUTICALS INC.
  • PIRAMAL HEALTHCARE LTD.
  • POLAR ELECTRO OY
  • PRESTIGE BRANDS HOLDINGS INC.
  • PREVENTICE INC.
  • PRIZM MEDICAL INC.
  • PROPELLER HEALTH
  • PROTEOSTASIS THERAPEUTICS
  • PROTEUS DIGITAL HEALTH INC.
  • QARDIO
  • RECKITT BENCKISER (NORTH AMERICA) INC.
  • RECKITT BENCKISER PLC.
  • RECORDATI PHARMA GMBH
  • REHAB-ROBOTICS (A MEMBER OF VINCENT MEDICAL HOLDINGS)
  • REVOLYMER (U.K.) LTD
  • REXAHN PHARMACEUTICALS
  • ROCHE
  • SAGE PRODUCTS LLC
  • SAGE THERAPEUTICS
  • SANOFI
  • SAREPTA THERAPEUTICS
  • SATO PHARMACEUTICAL CO. LTD.
  • SENSE4CARE
  • SENSEONICS HOLDINGS
  • SENTICARE INC.
  • SHAKLEE CORP.
  • SHANGHAI PHARMACEUTICALS HOLDING
  • SHIONOGI AND CO. LTD.
  • SILVERGENS
  • SPROUTLING INC. (ACQUIRED BY MATTEL)
  • ST. JUDE MEDICAL (A SUBSIDIARY OF ABBOTT LABORATORIES)
  • STADA ARZNEIMITTEL AG
  • SUMITOMO DAINIPPON PHARMA CO. LTD.
  • SUN PHARMACEUTICAL INDUSTRIES
  • SWISSE WELLNESS PTY LTD.
  • TAISHO PHARMACEUTICAL HOLDINGS
  • TAISHO PHARMACEUTICAL
  • TAKEDA PHARMACEUTICAL CO. LTD.
  • TCR2 THERAPEUTICS
  • TEVA PHARMACEUTICAL INDUSTRIES
  • TISSO NATURPRODUKTE GMBH
  • TOWERVIEW HEALTH INC.
  • TRANSLATE BIO
  • TYME TECHNOLOGIES
  • UCB
  • UNILIFE CORP.
  • VAICA
  • VERTEX PHARMACEUTICAL
  • VITAL CONNECT
  • WELLSPRING PHARMACEUTICAL CORP.
  • WEST PHARMACEUTICAL SERVICES INC.
  • WINMEDICAL SRL
  • YBRAIN
  • YPSOMED HOLDING AG
  • ZEAVISION LLC
  • ZOGENIX INC.
  • ZYDUS CADILA

Chapter 14 Appendix A: List of Acronyms

Chapter 15 Appendix B: Professional Organizations

  • American Heart Association
  • Center for Drug Evaluation and Research (CDER)
  • Center for Devices and Radiological Health (CDRH)
  • Centers for Medicare and Medicaid Services (CMS)
  • European Databank for Medical Devices (EUDAMED)
  • Food and Drug Administration (FDA or U.S. FDA)
  • Hormone Foundation
  • International Diabetes Federation (IDF)
  • International Federation of Pharmaceutical Manufacturers and Associations (IFPMA)
  • Network for Excellence in Health Innovation (NEHI)
  • National Center for Biotechnology Information (NCBI)
  • National Institute of Aging (NIA)
  • Pharmaceuticals and Medical Devices Agency (PMDA)
  • World Cancer Research Fund International
  • World Health Organization (WHO)